Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Unexplained Recurrent Pregnancy Loss
NCT02379650Phase 2Withdrawn
- Sponsor
- University of Utah
- Start
- Jul 2016
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in recurrent pregnancy loss (RPL), sponsored by University of Utah. Planned start Jul 2016; status: withdrawn.
02
Drugs
hydroxychloroquine
03
Conditions
recurrent pregnancy loss (RPL)
Beyond the preview
Go deeper on NCT02379650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02379650.